|
|
Article: Bedford Laboratories(TM) to Begin Shipping Pentostatin for Injection.
- Article from:
- PR Newswire
- Article date:
- August 14, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BEDFORD, Ohio, Aug. 13 /PRNewswire/ -- Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., announced FDA approval to begin shipping Pentostatin for Injection. This product is AP rated and is equivalent to Nipent(R) by Hospira Inc. Pentostatin is indicated for the treatment of hairy cell leukemia.
(Logo: http://www.newscom.com/cgi-bin/prnh/20070809/CLTH157LOGO )
"In our continuing effort to offer the most comprehensive and cost effective line of oncology and oncology adjunct products in the multisource industry, Bedford Laboratories is once again very pleased to offer this very important product," said David Gaugh, Vice President of ...